G. Ralph

Oxford BioMedica (United Kingdom) — United Kingdom

Medicine · Health Sciences

20h-index3.2kcitations57works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Maternal and Perinatal Health Interventions(6), Virus-based gene therapy research(6), Neurological disorders and treatments(6), Nerve injury and regeneration(5), RNA Interference and Gene Delivery(5)

Publications54 total

Deep brain stimulation is well tolerated and effective following ProSavin® gene therapy for Parkinson's disease
Neurotherapeutics·2025· 1 citedOpen Access
Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis
Molecular Therapy — Methods & Clinical Development·2019· 23 citedOpen Access
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
Human Gene Therapy Clinical Development·2018· 137 citedOpen Access
Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates
Scientific Reports·2018· 16 citedOpen Access
Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates
DSpace@MIT (Massachusetts Institute of Technology)·2018Open Access
Separate elements of episodic memory subserved by distinct hippocampal–prefrontal connections
Nature Neuroscience·2017· 123 citedOpen Access
Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease
Human Gene Therapy Clinical Development·2016· 24 cited
Case report: Postpartale Uterusruptur im Zustand nach Sectio
Geburtshilfe und Frauenheilkunde·2016
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
The Lancet·2014· 433 cited
Traitement de la maladie de Parkinson par thérapie génique de la dopamine (ProSavin®) résultats d’un essai clinique de phase I
Revue Neurologique·2013
A Stable Producer Cell Line for the Manufacture of a Lentiviral Vector for Gene Therapy of Parkinson's Disease
Human Gene Therapy·2010· 41 cited
Desmoplastisches Malignes Melanom der Mamma: ein Fallbericht
Geburtshilfe und Frauenheilkunde·2010
Mikrometastasen im Sentinel Lymphknoten bei Patientinnen mit Mammakarzinom: Indikationsstellung zur Chemotherapie
Geburtshilfe und Frauenheilkunde·2010· 1 cited
Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia
Science Translational Medicine·2009· 177 cited
Prognose von Patientinnen mit sehr kleinem, nodal negativem Mammakarzinom in Assoziation zur Hormonrezeptor- und HER2-Expression
Geburtshilfe und Frauenheilkunde·2008
Empfehlungen der Arbeitsgemeinschaft Urogynäkologie zur Sonographie des unteren Harntraktes im Rahmen der urogynäkologischen Funktionsdiagnostik
Ultraschall in der Medizin - European Journal of Ultrasound·2008· 7 cited
Determination of the profile and site preference of lentiviral vector integration in primary astrocyte cultures
Blood Cells Molecules and Diseases·2008
Survival of patients with small HER2 positive, node negative breast cancer and implications for treatment with trastuzumab
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2007
Retrospective Comparison of Chemotherapy-Induced Myelotoxicity in Patients with Ovarian Cancer Under and Over 60 Years of Age
Journal of Chemotherapy·2006· 5 cited
Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors
Clinical Science·2005· 35 cited
page 1 of 3Next →

Frequent Co-authors

Kyriacos Mitrophanous(15), Nicholas D. Mazarakis(9), E. Hanzal(9), Susan M. Kingsman(8), James B. Uney(7), H. Kölbl(7), Mimoun Azzouz(6), Stéphane Palfi(6), Ossi R. Köchli(6), N. Vavra(6), H Kölbl(6), Philippe Hantraye(5), Jeremy M. Henley(5), Hannah J. Stewart(5), W. Lichtenegger(5), M. Lahousen(5), Liang‐Fong Wong(4), Xavier Drouot(4), Roger A. Barker(4), F Peintinger(4)